Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C15H20HgNO6.C13H20N2O2.HO |
| Molecular Weight | 764.23 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[OH-].CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.COCCOC(C[Hg+])CNC(=O)C2=C(OCC(O)=O)C=CC=C2
InChI
InChIKey=XRCLWOYOVQUZLE-UHFFFAOYSA-M
InChI=1S/C15H20NO6.C13H20N2O2.Hg.H2O/c1-11(21-8-7-20-2)9-16-15(19)12-5-3-4-6-13(12)22-10-14(17)18;1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11;;/h3-6,11H,1,7-10H2,2H3,(H,16,19)(H,17,18);5-8H,3-4,9-10,14H2,1-2H3;;1H2/q;;+1;/p-1
Merethoxylline is a mercurial diuretic. As an equimolar mixture of merethoxylline procaine and theophylline in the molecular proportion 1:1.4 (DICURIN PROCAINE, Lilly) has been used in the treatment of oedema and ascites. The procaine component helps in reducing the discomfort of local irritation caused by mercurial compound when injected into tissues.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0070294 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | DICURIN PROCAINE Approved UseDICURIN PROCAINE has been used in the treatment of oedema and ascites. Launch Date1981 |
|||
| Primary | DICURIN PROCAINE Approved UseDICURIN PROCAINE has been used in the treatment of oedema and ascites. Launch Date1981 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Mon Mar 31 17:45:55 GMT 2025 , Edited by admin on Mon Mar 31 17:45:55 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
O77D636VYN
Created by
admin on Mon Mar 31 17:45:55 GMT 2025 , Edited by admin on Mon Mar 31 17:45:55 GMT 2025
|
PRIMARY | |||
|
CHEMBL1200443
Created by
admin on Mon Mar 31 17:45:55 GMT 2025 , Edited by admin on Mon Mar 31 17:45:55 GMT 2025
|
PRIMARY | |||
|
4992
Created by
admin on Mon Mar 31 17:45:55 GMT 2025 , Edited by admin on Mon Mar 31 17:45:55 GMT 2025
|
PRIMARY | |||
|
C132291
Created by
admin on Mon Mar 31 17:45:55 GMT 2025 , Edited by admin on Mon Mar 31 17:45:55 GMT 2025
|
PRIMARY | |||
|
72710718
Created by
admin on Mon Mar 31 17:45:55 GMT 2025 , Edited by admin on Mon Mar 31 17:45:55 GMT 2025
|
PRIMARY | |||
|
60064-28-0
Created by
admin on Mon Mar 31 17:45:55 GMT 2025 , Edited by admin on Mon Mar 31 17:45:55 GMT 2025
|
PRIMARY | |||
|
DB09364
Created by
admin on Mon Mar 31 17:45:55 GMT 2025 , Edited by admin on Mon Mar 31 17:45:55 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD